Amoroso Michael

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
13
Insider Sells Sum
$354,586.70

Insider Activity of Amoroso Michael

According to the SEC Form 4 filings, Amoroso Michael, being in a position of

  1. President and CEO at Precision BioSciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 141928 shares for $89,877,
    over all time since 2022-10-17, has bought 0 shares, and sold 324958 shares for $192,954.

The largest sale of all time was on 2021-03-31 and amounted to 45409 shares of Abeona Therapeutics Inc. for $84,919.

Biography of Amoroso Michael

No biography is available at this moment.

2024-11-04SalePrecision BioSciences, Inc.
DTIL
President and CEO
3,012
0.0412%
$8.19$24,668-19.42%
2024-05-02SalePrecision BioSciences, Inc.
DTIL
President and CEO
1,526
0.021%
$10.32$15,748-11.72%
2024-01-22SalePrecision BioSciences, Inc.
DTIL
President and CEO
137,390
0.1111%
$0.36$49,460+2,577.8%
2023-11-03SalePrecision BioSciences, Inc.
DTIL
President and CEO
125,025
0.1021%
$0.40$50,010+2,183.83%
2023-09-27SaleAbeona Therapeutics Inc.
ABEO
director
5,508
0.022%
$3.91$21,542+20.96%
2023-09-20SaleAbeona Therapeutics Inc.
ABEO
director
327
0.0014%
$3.90$1,275+25.53%
2023-06-20SaleAbeona Therapeutics Inc.
ABEO
director
338
0.0039%
$4.45$1,504-3.52%
2023-03-22SalePrecision BioSciences, Inc.
DTIL
President and CEO
46,999
0.0438%
$0.82$38,539-33.5%
2023-03-20SaleAbeona Therapeutics Inc.
ABEO
director
268
0.0032%
$2.33$624+80%
2023-03-03SaleAbeona Therapeutics Inc.
ABEO
director
1,002
0.0112%
$2.38$2,385+60.47%
2022-10-17SalePrecision BioSciences, Inc.
DTIL
President and CEO
11,006
0.0119%
$1.32$14,528-40.65%
2021-09-30SaleAbeona Therapeutics Inc.
ABEO
Chief Executive Officer
45,409
0.0421%
$1.09$49,382-77.68%
2021-03-31SaleAbeona Therapeutics Inc.
ABEO
Chief Executive Officer
45,409
0.0468%
$1.87$84,919-41.49%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.